Teacher Retirement System of Texas’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $256K | Sell |
26,859
-2,784
| -9% | -$21.6K | ﹤0.01% | 1346 |
|
|
2025
Q4 | $231K | Sell |
29,643
-19,179
| -39% | -$139K | ﹤0.01% | 1500 |
|
|
2025
Q3 | $371K | Sell |
48,822
-4,679
| -9% | -$39K | ﹤0.01% | 1650 |
|
|
2025
Q2 | $479K | Buy |
53,501
+540
| +1% | +$5.03K | ﹤0.01% | 1564 |
|
|
2025
Q1 | $397K | Sell |
52,961
-5,330
| -9% | -$43K | ﹤0.01% | 1616 |
|
|
2024
Q4 | $438K | Buy |
58,291
+11,711
| +25% | +$88.9K | ﹤0.01% | 1295 |
|
|
2024
Q3 | $354K | Buy |
46,580
+5,836
| +14% | +$44.4K | ﹤0.01% | 1299 |
|
|
2024
Q2 | $252K | Sell |
40,744
-288
| -0.7% | -$1.59K | ﹤0.01% | 1425 |
|
|
2024
Q1 | $208K | Sell |
41,032
-2,795
| -6% | -$15.7K | ﹤0.01% | 1571 |
|
|
2023
Q4 | $263K | Sell |
43,827
-9,813
| -18% | -$56.9K | ﹤0.01% | 1598 |
|
|
2023
Q3 | $380K | Buy |
53,640
+2,519
| +5% | +$18.1K | ﹤0.01% | 1501 |
|
|
2023
Q2 | $360K | Sell |
51,121
-6,309
| -11% | -$50.6K | ﹤0.01% | 1562 |
|
|
2023
Q1 | $479K | Buy |
57,430
+1,352
| +2% | +$13K | ﹤0.01% | 1501 |
|
|
2022
Q4 | $644K | Sell |
56,078
-4,973
| -8% | -$62K | ﹤0.01% | 1361 |
|
|
2022
Q3 | $769K | Buy |
61,051
+32,310
| +112% | +$416K | 0.01% | 1305 |
|
|
2022
Q2 | $304K | Sell |
28,741
-7,601
| -21% | -$78.4K | ﹤0.01% | 1429 |
|
|
2022
Q1 | $591K | Buy |
36,342
+2,201
| +6% | +$35.3K | ﹤0.01% | 1302 |
|
|
2021
Q4 | $473K | Buy |
34,141
+6,510
| +24% | +$86.2K | ﹤0.01% | 1518 |
|
|
2021
Q3 | $397K | Buy |
27,631
+4,708
| +21% | +$74.2K | ﹤0.01% | 1497 |
|
|
2021
Q2 | $362K | Buy |
22,923
+3,458
| +18% | +$47K | ﹤0.01% | 1456 |
|
|
2021
Q1 | $198K | Buy |
19,465
+3,652
| +23% | +$37.7K | ﹤0.01% | 1663 |
|
|
2020
Q4 | $118K | Buy |
+15,813
| New | +$81.5K | ﹤0.01% | 1506 |
|
|
2018
Q3 | – | Sell |
-14,060
| Closed | -$81K | – | 1585 |
|
|
2018
Q2 | $81K | Sell |
14,060
-7,713
| -35% | -$42.5K | ﹤0.01% | 1902 |
|
|
2018
Q1 | $104K | Sell |
21,773
-9,822
| -31% | -$50.5K | ﹤0.01% | 1884 |
|
|
2017
Q4 | $155K | Buy |
+31,595
| New | +$153K | ﹤0.01% | 2143 |
|
|
2016
Q3 | – | Sell |
-8,224
| Closed | -$23K | – | 1472 |
|
|
2016
Q2 | $23K | Buy |
8,224
+615
| +8% | +$1.91K | ﹤0.01% | 2494 |
|
|
2016
Q1 | $22K | Buy |
7,609
+2,268
| +42% | +$10.1K | ﹤0.01% | 2476 |
|
|
2015
Q4 | $55K | Sell |
5,341
-1,765
| -25% | -$17.6K | ﹤0.01% | 1997 |
|
|
2015
Q3 | $81K | Buy |
7,106
+4,868
| +218% | +$65K | ﹤0.01% | 1862 |
|
|
2015
Q2 | $33K | Buy |
2,238
+496
| +28% | +$5.64K | ﹤0.01% | 1815 |
|
|
2015
Q1 | $16K | Buy |
1,742
+3
| +0.2% | +$31 | ﹤0.01% | 2067 |
|
|
2014
Q4 | $21K | Sell |
1,739
-283
| -14% | -$3.13K | ﹤0.01% | 1858 |
|
|
2014
Q3 | $20K | Buy |
2,022
+365
| +22% | +$4.47K | ﹤0.01% | 1819 |
|
|
2014
Q2 | $21K | Hold |
1,657
| – | – | ﹤0.01% | 1927 |
|
|
2014
Q1 | $18K | Buy |
1,657
+24
| +1% | +$256 | ﹤0.01% | 1816 |
|
|
2013
Q4 | $12K | Buy |
+1,633
| New | +$10.3K | ﹤0.01% | 2031 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC
Teacher Retirement System of Texas's BCRX Position: Q1 2026 in Review
Teacher Retirement System of Texas reduced its BioCryst Pharmaceuticals (BCRX) stake by 9.4% in Q1 2026, selling an estimated $21.6K and leaving 26,859 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #1346.
Teacher Retirement System of Texas first reported a position in BCRX in Q4 2013 and has held it in 36 quarters since. The position peaked at $769K in Q3 2022. 301 funds tracked by Wall St. Rank hold BCRX as of Q1 2026.
- Teacher Retirement System of Texas held 26,859 shares of BioCryst Pharmaceuticals worth $256K as of Q1 2026.
- Teacher Retirement System of Texas sold 2,784 BioCryst Pharmaceuticals shares in Q1 2026, an estimated $21.6K.
- BioCryst Pharmaceuticals made up ﹤0.01% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #1346 holding.
- Teacher Retirement System of Texas first reported a position in BioCryst Pharmaceuticals in Q4 2013 and has held it in 36 quarters since.
- Teacher Retirement System of Texas's BioCryst Pharmaceuticals position peaked at $769K in Q3 2022.
- 301 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2026.
Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.